GlassScriptPhysician profile
Aime Castillo Mazantini
NPI 1346622081
$349.26
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $96.24 · 2023: $108 · 2024: $36.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $102.84 | 2021-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| W. L. Gore & Associates, INC. | $75.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.16 | 2023-2024 | Xifaxan |
| Gilead Sciences, INC. | $21.74 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.90 | 2022 | |
| Viiv Healthcare Company | $16.17 | 2024 | Dovato |
| Teva Pharmaceuticals USA, INC. | $16.17 | 2023 | Uzedy |
| Xeris Pharmaceuticals, INC. | $16.00 | 2023 | Gvoke Hypopen |
| Cranial Technologies, INC | $14.22 | 2023 | Doc Band |
| Organon LLC | $14.17 | 2022-2023 | Nexplanon |
| Janssen Pharmaceuticals, INC | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aime Castillo Mazantini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.